Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Plos One
|
June 15, 2016
Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer
Deborah R Kaye, Peter A Pinto, Fabiola Cecchi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 1, 2011
Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression
Tanja Grkovic, Emily L Whitson, Daniel C Rabe, et al.
Gene Therapy
|
April 18, 2006
Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice
V Schmitz, H Vilanueva, E Raskopf, et al.
Cancer Cell
|
August 18, 2012
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling
Fabiola Cecchi, Deborah Pajalunga, C Andrew Fowler, et al.
Plos One
|
May 13, 2021
Isolation of intact extracellular vesicles from cryopreserved samples
Shannon N Tessier, Lauren D Bookstaver, Cindy Angpraseuth, et al.
Investigational New Drugs
|
September 27, 2015
Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors
Geoffrey I Shapiro, Stewart McCallum, Laurel M Adams, et al.
Journal of Extracellular Vesicles
|
October 9, 2025
Signal Amplification for Fluorescent Staining of Single Particles in Liquid Biopsies: Circulating Tumour Cells and Extracellular Vesicles
Sara Cavallaro, Sara I Veiga, Raheel Ahmad, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2020
Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells
Avanish Mishra, Taronish D Dubash, Jon F Edd, et al.
The Journal of Prevention of Alzheimer'S Disease
|
June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
D Angioni, O Hansson, R J Bateman, et al.
Plos One
|
March 22, 2013
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer
Manish A Shah, Zev A Wainberg, Daniel V T Catenacci, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Plos One
|
June 15, 2016
Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer
Deborah R Kaye, Peter A Pinto, Fabiola Cecchi, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 1, 2011
Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2α induced gene expression
Tanja Grkovic, Emily L Whitson, Daniel C Rabe, et al.
Gene Therapy
|
April 18, 2006
Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice
V Schmitz, H Vilanueva, E Raskopf, et al.
Cancer Cell
|
August 18, 2012
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling
Fabiola Cecchi, Deborah Pajalunga, C Andrew Fowler, et al.
Plos One
|
May 13, 2021
Isolation of intact extracellular vesicles from cryopreserved samples
Shannon N Tessier, Lauren D Bookstaver, Cindy Angpraseuth, et al.
Investigational New Drugs
|
September 27, 2015
Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors
Geoffrey I Shapiro, Stewart McCallum, Laurel M Adams, et al.
Journal of Extracellular Vesicles
|
October 9, 2025
Signal Amplification for Fluorescent Staining of Single Particles in Liquid Biopsies: Circulating Tumour Cells and Extracellular Vesicles
Sara Cavallaro, Sara I Veiga, Raheel Ahmad, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 10, 2020
Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells
Avanish Mishra, Taronish D Dubash, Jon F Edd, et al.
The Journal of Prevention of Alzheimer'S Disease
|
June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force
D Angioni, O Hansson, R J Bateman, et al.
Plos One
|
March 22, 2013
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer
Manish A Shah, Zev A Wainberg, Daniel V T Catenacci, et al.
Page
of 6